Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy
暂无分享,去创建一个
Andrew Phillips | Esteban Martínez | Xavier Carné | A. Mocroft | A. Cruceta | J. Gatell | A. Phillips | J. Mallolas | E. Martinez | J. Blanco | A. Milinkovic | X. Carné | Amanda Mocroft | José L. Blanco | Ana Milinkovic | Juan A. Arnaiz | José B. Pérez-Cuevas | Anna Cruceta | María A. Marcos | Miguel A. García-Viejo | Josep Mallolas | José M. Gatell | M. García-Viejo | J. Arnaiz | M. Marcos | J. Pérez-Cuevas
[1] R. Gish. Severe liver toxicity in patients receiving two nucleoside analogues and a non-nucleoside reverse transcriptase inhibitor , 2001 .
[2] P. Reiss,et al. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection , 2000, AIDS.
[3] H. Kessler,et al. The Art of Physical Diagnosis—Reply , 2000 .
[4] D. Cooper,et al. Adverse effects of antiretroviral therapy , 2000, The Lancet.
[5] G. Carosi,et al. Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment. , 2000, The Journal of infectious diseases.
[6] K. Blankenship,et al. Structural interventions in public health , 2000, AIDS.
[7] R. Fullilove,et al. The Family to Family program: a structural intervention with implications for the prevention of HIV/AIDS and other community epidemics , 2000, AIDS.
[8] R. Chaisson,et al. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. , 2000, JAMA.
[9] F. Donato,et al. Mortality for liver disease in patients with HIV infection: a cohort study. , 2000, Journal of acquired immune deficiency syndromes.
[10] P. Couzigou,et al. Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996-1998. Groupe dEpidémiologie Clinique de Sida en Aquitaine (GECSA). , 1999, AIDS.
[11] P. Cadrobbi,et al. Severe hepatic failure related to nevirapine treatment. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] M. French,et al. Hepatitis C virus‐associated hepatitis following treatment of HIV‐infected patients with HIV protease inhibitors: an immune restoration disease? , 1998, AIDS.
[13] J. Smeitink,et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway , 1998, AIDS.
[14] C. Manthous,et al. Nevirapine-induced hepatitis treated with corticosteroids? , 1998, AIDS.
[15] P. Beaune,et al. Immunotoxicology of the liver: adverse reactions to drugs. , 1997, Journal of hepatology.